Breast Implants

5.2% Global CAGR for Breast Implants Market to achieve US$ 2,278.40 Mn by 2027

Mentor Worldwide LLC and Allergan plc. – Notable Market Participants in Breast Implants Market

The breast implants market is highly competitive in nature with significant number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the breast implants market are present globally and have wide distribution and sales network through partnerships or authorized dealers.

The most notable market participants are Allergan plc., Mentor Worldwide LLC (J&J), GC Aesthetics, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Ideal Implant Incorporated, Silimed, Group Sebbib SAS, Guangzhou Wanhe Plastic Materials Co., Ltd, and HANSBIOMED CO. LTD. occupying a considerable share of the market owing to their diverse product offerings to the market.

Market leaders are involved in expanding their business through organic or inorganic activities such as, acquisition, product launches and product approval. For instance, in 2017, Allergan plc. has carried out various important business developments such as acquisition of Keller Medical, Inc., Zeltiq Aesthetics, Inc., and LifeCell Corporation. The acquisitions have helped the company positively to expand their product offerings as well as expand their consumer base at a global level. Additionally, in January 2017, Allergan received FDA approval for the commercialization of to market NATRELLE INSPIRA SoftTouch breast implants, which provides women undergoing breast reconstruction, augmentation or revision surgery a new medium firmness gel. Subsequently, these activities are expected to provide the market with lucrative growth opportunities.

Many well-known as well as small local companies are present in the market to provide diversified product to its customers. The larger market players are adopting the strategy such as acquiring small firms to enhance its product portfolio and expand its footprint in different geographies. Additionally, various companies are also undergoing other strategic alliances such as collaboration, agreements and partnerships to garner their significance and remain competitive in the market. Few on the important key developments from the industry are mentioned below:





Sientra, Inc. acquired the dedicated FDA-approved, silicone breast implant manufacturing operations of Lubrizol Life Science located in Franklin, Wisconsin. This acquisition has helped the company strengthen its business operations worldwide

North America


Allergan acquired LifeCell Corporation which is a regenerative medicine company. The acquisition will combine regenerative medicines business, LifeCell’s novel with the Allergan’s products such as breast implants and tissue expanders and medical aesthetics.



Sientra acquired Specialty Surgical Products, Inc. (SSP), with this acquisition the company will enhance it product portfolio of Dermaspan and AlloX2 lines of breast tissue expanders products.

North America


Sientra signed service agreement with Vesta, a Lubrizol LifeSciences company. Under this agreement Vesta is inaugurating manufacturing unit for Sientra and serve a long-term supply agreement for its PMA-approved breast implants.

North America


Establishment Labs has entered into a partnership with Puregraft. The agreement is made to provide additional option of distribution of the Puregraft’s products in the US and Canada and also to transfer autologous fat transfer products of Puregraft.

Central America


Leave a Reply

Your email address will not be published. Required fields are marked *